Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.55 USD | 0.00% |
|
0.00% | +4.94% |
May. 15 | Athira Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 15 | Athira Pharma, Inc. Appoints Javier San Martin, M.D., as Chief Medical Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.94% | 97.74M | |
+49.41% | 57.87B | |
+41.65% | 40.25B | |
-6.72% | 39.94B | |
-5.96% | 28.54B | |
+12.99% | 26.4B | |
-19.82% | 19.33B | |
+32.35% | 12.4B | |
-0.08% | 12.23B | |
+25.18% | 12.2B |
- Stock Market
- Equities
- ATHA Stock
- News Athira Pharma, Inc.
- Berenberg Bank Initiates Coverage on Athira Pharma With Buy Rating, $33 Price Target